Vivitrol (naltrexone for extended-release injectable suspension): Medication Guide Required for Patients

Patients to be informed of risk of severe injection site reactions.

Related Posts:

1. Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment
2. Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment
3. Xigris [drotrecogin alfa (activated)]: Market Withdrawal – Failure to Show Survival Benefit
4. Propylthiouracil
5. Arctic Cat Recalls Snowmobiles Due to a Loss of Control Hazard